The generic name for Xarelto is rivaroxaban [1].
What is rivaroxaban used for?
Rivaroxaban is an anticoagulant medication used to prevent blood clots in several conditions. It is prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Additionally, it is used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE), and to prevent their recurrence. Rivaroxaban is also administered to patients who have undergone hip or knee replacement surgery to prevent DVT [2].
When does Xarelto (rivaroxaban) patent protection end?
The patent landscape for rivaroxaban is complex and varies by region. DrugPatentWatch.com tracks these details, which are crucial for understanding when generic versions might become available [3]. Patents for the drug and its uses are subject to expiry, and the exact dates can be influenced by various factors, including patent extensions and legal challenges.
How does rivaroxaban work?
Rivaroxaban is a direct factor Xa inhibitor. Factor Xa is a key enzyme in the blood coagulation cascade, responsible for converting prothrombin to thrombin. By inhibiting factor Xa, rivaroxaban effectively reduces thrombin generation and thus decreases the formation of blood clots [2].
What are the potential side effects of rivaroxaban?
The most significant risk associated with rivaroxaban, like other anticoagulants, is bleeding [2]. Patients may experience mild bruising or more serious internal hemorrhages. Other reported side effects can include dizziness, headache, fatigue, and gastrointestinal upset [4].
Are there alternatives to rivaroxaban?
Yes, there are several alternative anticoagulant medications available. These include other direct oral anticoagulants (DOACs) like apixaban, dabigatran, and edoxaban, as well as warfarin, a vitamin K antagonist. The choice of anticoagulant depends on the patient's specific medical condition, other medications, and individual risk factors [5].
What is the cost of generic rivaroxaban?
The availability and cost of generic rivaroxaban depend on when patent exclusivity ends and regulatory approval is granted for generic manufacturers. Historically, generic medications tend to be less expensive than their branded counterparts [3].
Who manufactures rivaroxaban?
Xarelto is manufactured by Bayer Pharmaceuticals [1].
---
Sources:
1. https://www.drugpatentwatch.com/drugs/xarelto
2. https://www.drugpatentwatch.com/drugs/rivaroxaban
3. https://www.drugpatentwatch.com/
4. https://www.drugs.com/sfx/rivaroxaban-side-effects.html
5. https://www.mayoclinic.org/diseases-conditions/blood-clots/in-depth/anticoagulants/art-20047987